News

Studies demonstrate superior efficacy of Xarelto against a comparator

Revolutionizing the prophylaxis of dangerous thromboses

Bayer’s Xarelto® (active ingredient: rivaroxaban) has demonstrated superior efficacy against a comparator in the prevention of venous thromboembolism following hip or knee-joint replacement surgery. » more

New herbicidal active ingredient presented
Doing away with weeds
Bayer CropScience presented a new herbicidal active ingredient called indaziflam for the first time at the 49th Annual Meeting of the Weed Science Society of America. » more

Good prospects for the future:
Carbon nanotubes – a key technology
Bayer MaterialScience can now market its multi-wall carbon nanotubes known as Baytubes® in the United States as well. » more

Energy saving in the industrial production
Chancellor Merkel visits Bayer at the Hanover Fair
How is it possible to sustainably save over 20 percent energy in an industrial production plant? » more